Dilution of equity value resulting from the exercise of stock acquisition rights
First written in FY2021. 8 of 10 entries say "Materialised", first in FY2022-Q1. Latest entry: FY2026.
Reform Technology moved to the "Worse" side of this theme in 2021, the same year as the typical company in this theme.
The whole theme swung hardest in 2017: 28 of 54 companies on the "Worse" side.
32 other companies' latest entry also says "Worsened".
- FY2026WorsenedAnnual report
「As of the date of filing this document, the Company had 7,469,100 issued shares. If these stock acquisition rights are exercised, 126,600 new shares may be issued, potentially diluting the value of the Company's shares on a per-share basis.」
The number of shares potentially issuable through stock acquisition rights was updated to 126,600, up from the previously stated 70,500. The total number of issued shares was 7,469,100 following a stock split, third-party allotment and other transactions. - FY2024-Q1MaterialisedAnnual report
「1 April 2023–30 June 2023 (Note) 10,300 2,274,400 468 268,858 468 188,858 (Note) Increase due to the exercise of stock acquisition rights.」
During the cumulative first-quarter period of FY2024, 10,300 shares were issued through the exercise of stock acquisition rights, and events that could lead to dilution in share value continued to occur. - FY2023MaterialisedAnnual report
「1 April 2022–31 March 2023 (Note 5) 14,000 2,264,100 6,930 268,389 6,930 188,389 (Note) 5. Increase due to the exercise of stock acquisition rights.」
During FY2023, 14,000 shares were issued through the exercise of stock acquisition rights, and events that could lead to dilution in share value continued to occur. - FY2023-Q3MaterialisedAnnual report
「1 October 2022–31 December 2022 (Note 1) 1,300 2,263,200 643 267,944 643 187,944 (Note) 1. Increase due to the exercise of stock acquisition rights.」
During the third-quarter accounting period of FY2023, 1,300 shares were issued through the exercise of stock acquisition rights, and events that could lead to dilution in share value continue to occur. - FY2023-Q2MaterialisedAnnual report
「1 July 2022–30 September 2022 (Note 1) 8,000 2,261,900 3,960 267,300 3,960 187,300 (Note) 1. Increase due to the exercise of stock acquisition rights.」
During the second-quarter accounting period of FY2023, 8,000 shares were issued through the exercise of stock acquisition rights, and events that could lead to dilution in share value continue to occur. - FY2023-Q1MaterialisedAnnual report
「1 April 2022–30 June 2022 (Note) 3,800 2,253,900 1,881 263,340 1,881 183,340 (Note) 1. Increase due to the exercise of stock acquisition rights. 2. Between 1 July 2022 and 31 July 2022, the total number of issued shares increased by 1,300 and capital stock and capital reserves each increased by ¥643 thousand through the exercise of stock acquisition rights.」
During the first quarter of FY2023, 3,800 shares were issued through the exercise of stock acquisition rights, and a further 1,300 shares were issued in July 2022 before the filing date. Events that could lead to dilution in share value continue to occur. - FY2022MaterialisedAnnual report
「The number of issued shares increased by 1,600 through the issuance of new shares upon the exercise of stock acquisition rights through 31 March 2022.」
During FY2022, 1,600 shares were issued through the exercise of stock acquisition rights, and events that could lead to dilution in share value continued to occur. - FY2022-Q3MaterialisedAnnual report
「1 October 2021–31 December 2021 (Note) 100 2,250,000 49 261,410 49 181,410 (Note) Increase due to the exercise of stock acquisition rights.」
During the third-quarter accounting period, 100 shares were issued through the exercise of stock acquisition rights, resulting in an additional event that could lead to dilution in share value. - FY2022-Q1MaterialisedAnnual report
「The increase resulted from the exercise of share acquisition rights.」
Between 1 April 2021 and 30 June 2021, 1,400 shares were issued through the exercise of stock acquisition rights, partially realizing the previously disclosed risk of dilution in share value. - FY2021First statedAnnual report
「As of the date of filing this document, the Company had 2,249,900 issued shares. If these stock acquisition rights are exercised, 70,500 new shares may be issued, potentially diluting the value of the Company's shares on a per-share basis.」
The dilution risk was quantified: 70,500 shares could be issued upon exercise of stock acquisition rights, compared with 2,249,900 issued shares.